世界の胃がん診断市場 – 業界動向と2030年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

世界の胃がん診断市場 – 業界動向と2030年までの予測

  • Healthcare IT
  • Published Report
  • Mar 2023
  • Global
  • 350 ページ
  • テーブル数: 689
  • 図の数: 86

世界の胃がん診断市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2024 –2030
Diagram 市場規模(基準年)
USD 1,950.82 million
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>世界の胃がん診断市場、製品タイプ別(機器、試薬・消耗品、サービス)、診断タイプ別(確定検査、胃がんスクリーニング検査/身体検査)、年齢層別(成人、小児、老年)、疾患タイプ別(腸管またはびまん性腺がん、カルチノイド腫瘍、消化管間質腫瘍(GIST)、胃リンパ腫など)、ステージ別(ステージ0、ステージI、ステージII、ステージIII)、性別別(男性、女性)、サンプルタイプ別(血液、組織、尿、便)、エンドユーザー別(診断研究所、病院、がん研究機関、腫瘍学専門クリニックなど)、流通チャネル別(直接入札および小売販売) - 2030年までの業界動向と予測。

胃がん診断市場

胃がん診断市場の分析と洞察

世界の高齢者人口の増加は、胃がん診断産業の成長を牽引しています。また、胃腸腫瘍やリンパ腫の蔓延も、胃がん診断の需要を刺激しています。市場の主な制約は、がん診断検査に関連する高額な価格を下げて、発展途上国でもその恩恵を受けられるようにする必要があることです。

胃がん診断市場胃がん診断市場

多数の市場プレーヤーが、世界的な胃がん診断市場の成長への道を開く革新的な胃がん診断製品を提供しています。

Data Bridge Market Research の分析によると、世界の胃がん診断市場は、予測期間中に 8% の CAGR で成長し、2030 年までに 19 億 5,082 万米ドルに達する見込みです。キットと試薬の需要が高まっているため、試薬と消耗品が市場で最大の製品タイプ セグメントを占めており、医療費の増加によりスマート医療機器の需要が加速しています。

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015~2020年にカスタマイズ可能)

定量単位

売上高(百万米ドル)、販売数量(個数)、価格(米ドル)

対象セグメント

製品タイプ別(機器、試薬・消耗品、サービス)、診断タイプ別(確定検査、胃がんスクリーニング検査/身体検査)、年齢層別(成人、小児、老年)、疾患タイプ別(腸管またはびまん性腺がん、カルチノイド腫瘍、消化管間質腫瘍(GIST)、胃リンパ腫など)、ステージ別(ステージ 0、ステージ I、ステージ II、ステージ III)、性別別(男性、女性)、サンプルタイプ別(血液、組織、尿、便)、エンドユーザー別(診断研究所、病院、がん研究機関、腫瘍専門クリニックなど)、流通チャネル別(直接入札および小売販売)

対象国

米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他のヨーロッパ諸国、日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、その他のアジア太平洋諸国、ブラジル、アルゼンチン、その他の南米諸国、サウジアラビア、南アフリカ、UAE、イスラエル、エジプト、その他の中東およびアフリカ諸国

対象となる市場プレーヤー

Myriad Genetics, Inc.、ACON Laboratories, Inc.、Teco Diagnostics.、Vela Diagnostics、Abbott、AdvaCare Pharma、Fujirebio(HUグループ企業)、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、General Electric、Agilent Technologies, Inc.、Endofotonics Pte Ltd、Biohit Oyj、BIOCEPT, INC.、FOUNDATION MEDICINE, INC.、DiaSorin SpA、Paragon Genomics, Inc.、BIOMÉRIEUX、QIAGENなど。

市場の定義

胃がんは、胃で発生し、全身に広がるがんの一種です。胃は、腹部の上部にある肋骨のすぐ下にある筋肉の袋です。胃は、私たちが食べた食べ物を取り込み、保持してから分解して消化します。胃がんは、一般的に胃がんと呼ばれ、胃のどの部分にも発生する可能性があります。胃がんは、世界のほとんどの地域で胃の主要部分(胃体部)に発生します。がんの診断に使用されるさまざまな診断テストには、事前スクリーニングテスト、生検、バイオマーカー、画像検査、PET/CTスキャン、超音波などがあります。

がんは、体の他の部位に広がり、侵入する能力を持つ、制御不能な異常な細胞増殖によって引き起こされます。遺伝子の変化により、1 個または数個の細胞が拡大して複製され、これががんの始まりです。これが腫瘍の成長につながる可能性があります。腫瘍とは、異常な組織の塊です。胃の内壁にがん細胞が形成されることを胃がんといいます。食事と胃の不調は、どちらも胃がんの危険因子です。

世界の胃がん診断市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。    

 ドライバー

  • 消化管腫瘍、リンパ腫、腺癌の発生率の増加

Clinical Medicine に掲載されたレポートによると、胃がんは 2020 年に世界で 5 番目に多いがんであり、がんによる死亡原因の第 4 位です。2020 年には、世界中で推定 110 万件 (男性 72 万人、女性 37 万人) の胃がんが診断されました。胃がんは、がんによる死亡者の約 12 人に 1 人を占めています。毎年、世界中で約 100 万件の胃がんの新規症例が診断されています。

高齢化や人口増加、ライフスタイル、社会経済的変化により、胃がんの発生率は上昇すると予測されています。人種、社会文化的規範、行動、食生活の傾向の著しい違いは、世界中のさまざまな地域におけるがんの負担と分布に反映されています。

したがって、世界中で癌の発生率が上昇していることから、胃癌診断の需要が加速すると予想されます。したがって、胃腸腫瘍、リンパ腫、腺癌の発生率の上昇が、世界の胃癌診断市場の成長を牽引すると予想されます。

  • アルコール消費量の増加と喫煙の急増

疫学的、臨床的、および実験的証拠は、喫煙とアルコール摂取の間に行動上の関係があることを示しています。タバコとアルコールの併用は、喫煙のみで生じる健康上の懸念に加えて健康上の懸念を生じさせるため、さらなる調査を必要とする深刻な公衆衛生問題となります。

喫煙者が火のついたタバコを吸い込むたびに化学連鎖反応が起こり、数十種類の有害な化学物質が生成されます。タバコの煙には、唇、舌、口から吸い込まれ、喉を通って肺に入る物質が含まれており、炎症を引き起こし、体の部位を発がん性化学物質にさらします。

したがって、アルコール消費量の増加と喫煙の急増が、世界の胃がん市場の成長を促進すると予想されます。

胃がん診断市場

機会

  • 自動化システムの導入増加

がんはシステムとネットワークの病気です。これは、がん細胞内で特定のネットワーク関連遺伝子が正常に機能しなくなることを示しています。がん治療では、このような遺伝子ネットワークの複雑な相互作用に対処する必要があります。特に、人工知能(AI) アルゴリズムは急速に進化しており、それが腫瘍学の進歩に反映されています。

機械学習とニューラル ネットワークは、精密腫瘍学とシステム医学においてますます重要になっています。画像データと臨床データおよび分子データを組み合わせることで、可能性の世界が広がります。たとえば、ラジオゲノミクスは、多次元データ処理に重点を置いた新しい分野です。この分野も AI の進歩の恩恵を受けることができます。

したがって、自動化システムの採用の増加は、この市場の成長の機会として機能します。

抑制/挑戦

  • 健康保険による十分な財政支援の欠如

保健医療制度が目標を達成するには、財源が必要です。ほとんどの保健医療制度において、最も費用がかかるのは人材、病院での治療、薬剤です。ほとんどの熱帯諸国では、保健医療は政府、民間(主に自己負担)の支出、および国際援助の組み合わせによって資金が賄われています。

医療財政は、低所得国および下位中所得国にとって依然として重要な懸念事項です。ラテンアメリカ、アフリカ、アジアの上位中所得国の多くは、国民の大部分を対象とする医療財政協定を確立しています。これらの措置により、医療へのアクセスが可能になると同時に、アクセスの結果として個人が負う破滅的な負債から保護されます。一方、低所得国(その大部分はサハラ以南のアフリカ)では、財政が医療提供の大きな障害となっています。

したがって、健康保険政策からの十分な財政支援の欠如は、市場の成長に対する制約として機能します。

最近の動向

  • 2022年10月、ゼネラル・エレクトリック社は、ケンブリッジ大学病院、ソフィア・ジェネティクス、そしてそれ以前にはオプテルムなどの複数の研究機関と協力し、人工知能と連携して画像データを活用しました。これにより、いくつかのがんの診断時間が短縮され、患者に個別化されたケアを提供するのに役立ちます。これにより、同社はがん診断の視野を広げることができました。
  • 2020年3月、サーモフィッシャーサイエンティフィック社は、オランダに拠点を置く分子診断およびヘルスケア企業であるQIAGENを買収すると発表しました。この買収により、同社の市場における製品ポートフォリオが拡大し、将来の収益増加につながります。

世界の胃がん診断市場の範囲

世界の胃がん診断市場は、製品タイプ、診断タイプ、年齢層、疾患タイプ、ステージ、性別、サンプル、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分割されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

製品タイプ

  • 楽器
  • 試薬・消耗品
  • サービス

製品タイプに基づいて、市場は機器、試薬と消耗品、およびサービスに分類されます。

診断タイプ

  • 確認テスト
  • 胃がん検診・健康診断

診断タイプに基づいて、市場は胃がんスクリーニング検査/身体検査と確認検査に分類されます。

年齢層

  • アダルト
  • 小児科
  • 老年医学

年齢層に基づいて、市場は成人、小児、老年に分類されます。

タイプ

  • 腸管またはびまん性腺癌
  • カルチノイド腫瘍
  • 消化管間質腫瘍(GIST)
  • 胃リンパ腫
  • その他

タイプに基づいて、市場は腸またはびまん性腺癌、カルチノイド腫瘍、消化管間質腫瘍(GIST)、胃リンパ腫、その他に分類されます。

ステージ

  • ステージ0
  • ステージI
  • ステージ II
  • ステージIII

ステージに基づいて、市場はステージ 0、ステージ I、ステージ II、ステージ III に分類されます。

性別

  • 女性

性別に基づいて、市場は男性と女性に分割されます。

サンプルタイプ

  • 組織
  • 尿
  • スツール

サンプルの種類に基づいて、市場は血液、組織、尿、および便に分類されます。

エンドユーザー

  • 診断検査室
  • 病院
  • がん研究機関
  • 腫瘍学専門クリニック
  • その他

エンドユーザーに基づいて、市場は診断研究所、病院、癌研究機関、腫瘍学専門クリニックなどに分類されます。

流通チャネル

  • 直接入札
  • 小売販売

流通チャネルに基づいて、市場は直接入札と小売販売に分割されます。

胃がん診断市場

世界の胃がん診断市場の地域分析/洞察

世界の胃がん診断市場は、製品タイプ、診断タイプ、年齢層、病気の種類、段階、性別、サンプル、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分類されています。  

この市場レポートで取り上げられている国は、米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他のヨーロッパ諸国、日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、その他のアジア太平洋諸国、ブラジル、アルゼンチン、その他の南米諸国、サウジアラビア、南アフリカ、UAE、イスラエル、エジプト、その他の中東およびアフリカ諸国です。

消化管腫瘍の罹患率の上昇により、北米は世界の胃がん診断市場を支配すると予想されています。米国は主要企業の強力な存在により、北米地域で優位に立っています。ドイツは新興市場からの需要の増加と拡大により、ヨーロッパ地域で優位に立っています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

胃がん診断市場

競争環境と胃がん診断市場シェア分析

世界の胃がん診断市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と広さ、アプリケーションの優位性、および製品タイプのライフライン曲線が含まれます。上記のデータ ポイントは、胃がん診断市場への会社の重点にのみ関連しています。

世界の胃がん診断市場で活動している主要企業としては、Myriad Genetics, Inc.、ACON Laboratories, Inc.、Teco Diagnostics.、Vela Diagnostics、Abbott、AdvaCare Pharma、Fujirebio(HUグループ企業)、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、General Electric、Agilent Technologies, Inc.、Endofotonics Pte Ltd、Biohit Oyj、BIOCEPT, INC.、FOUNDATION MEDICINE, INC.、DiaSorin SpA、Paragon Genomics, Inc.、BIOMÉRIEUX、QIAGENなどが挙げられます。

 


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL gastric cancer diagnostics market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. packaging LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET END USER COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. ROLE OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) IN GASTRIC CANCER DIAGNOSTICS
    2. products (brands) Detailed information
  5. REGULATIONS OF GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET
  6. Epidemiology
  7. market overview
    1. DRIVERS
      1. INCREASE IN INCIDENCE OF GASTROINTESTINAL TUMOURS, LYMPHOMA, AND ADENOCARCINOMA
      2. RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING
      3. INCREASE IN THE GERIATRIC POPULATION
      4. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      5. RECENT ADVANCES IN GASTRIC CANCER DIAGNOSTICS
    2. RESTRAINTS
      1. HIGH COST OF TESTING
      2. LACK OF SUFFICIENT FINANCIAL SUPPORT FROM HEALTH INSURANCE POLICIES
    3. OPPORTUNITIES
      1. RISING HEALTHCARE SPENDING
      2. ADOPTION OF AUTOMATED SYSTEMS
      3. INCREASED RESEARCH AND DEVELOPMENT ON CANCER DIAGNOSTICS
    4. CHALLENGES
      1. STRINGENT REGULATIONS AND POLICIES FOR APPROVING THE COMPLICATED NATURE OF RADIATION DEVICES
      2. LIMITATIONS OF RADIATION TESTS
  8. IMPACT OF COVID-19 ON GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    5. CONCLUSION
  9. global gastric cancer diagnostics market, By product type
    1. overview
    2. Reagents & Consumables
      1. Kits
        1. DNA POLYMERASE KITS
        2. PCR KITS
        3. NUCLEIC ACID ISOLATION KITS
        4. OTHERS
      2. Reagents
        1. ASSAYS
        2. BUFFERS
        3. PRIMERS
        4. OTHERS
    3. instruments
    4. services
  10. global gastric cancer diagnostics market, By diagnostic type
    1. overview
    2. confirmatory test
      1. imaging tests
        1. PET SCAN/CT SCAN
        2. CT SCAN
        3. ULTRASOUND
        4. MRI
        5. X-RAY
      2. biomarker
        1. DNA BIOMARKER
        2. RNA BIOMARKER
        3. PROTEIN BIOMARKER
      3. biopsy
    3. gastric cancer screening tests/physical exam
  11. global gastric cancer diagnostics market, By age group
    1. overview
    2. geriatrics
    3. adult
    4. pediatric
  12. global gastric cancer diagnostics market, By disease type
    1. overview
    2. intestinal or diffuse adenocarcinoma
    3. carcinoid tumor
    4. gastrointestinal stromal tumor
    5. gastric lymphoma
    6. others
  13. global gastric cancer diagnostics market, By stage
    1. overview
    2. stage i
      1. stage iA
      2. stage iB
    3. stage iI
      1. stage IiA
      2. stage IiB
    4. stage iII
      1. stage IiIA
      2. stage IiIB
      3. stage IiIC
    5. stage 0
  14. global gastric cancer diagnostics market, By GENDER
    1. overview
    2. male
    3. female
  15. global gastric cancer diagnostics market, By sample type
    1. overview
    2. stool
    3. tissue
    4. blood
    5. urine
  16. global gastric cancer diagnostics market, By end user
    1. overview
    2. hospitals
    3. diagnostic laboratories
    4. cancer research institutes
    5. oncology specialty clinics
    6. others
  17. global gastric cancer diagnostics market, By distribution channel
    1. overview
    2. direct tenders
    3. Retail Sales
  18. GLOBAL gastric cancer diagnostics MARKET, BY REGION
    1. overview
    2. NORTH AMERICA
      1. U.S.
      2. Canada
      3. Mexico
    3. EUROPE
      1. Germany
      2. France
      3. U.K.
      4. Russia
      5. Italy
      6. Spain
      7. Belgium
      8. Netherlands
      9. Turkey
      10. Switzerland
      11. Rest of Europe
    4. Asia-Pacific
      1. South Korea
      2. JAPAN
      3. CHINA
      4. AUSTRALIA
      5. Singapore
      6. India
      7. THAILAND
      8. Malaysia
      9. INDONESIA
      10. PHILIPPINES
      11. Rest of ASIA-PACIFIC
    5. SOUTH AMERICA
      1. Brazil
      2. Argentina
      3. Rest of South America
    6. MIDDLE EAST AND AFRICA
      1. South Africa
      2. Saudi Arabia
      3. U.A.E.
      4. Egypt
      5. Israel
      6. Rest of Middle East & Africa
  19. GLOBAL Gastric Cancer diagnostics Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  20. SWOT
  21. Company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. GENERAL ELECTRIC COMPANY
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. BIOMÉRIEUX SA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. ACON Laboratories, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. ADVACARE PHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. AGILENT TECHNOLOGIES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. BIOCEPT, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Biohit Oyj
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. DiaSorin S.p.A
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. Endofotonics Pte Ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. foundation medicine, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. fujirebio (an h.u. group company)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. MiRXES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Paragon Genomics, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. qiagen
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    18. teco diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. vela diagnostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  22. questionnaire
  23. related reports

表のリスト

TABLE 1 global gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 2 Global reagents & consumables in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 3 global Reagent and consumables IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 4 global kits IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 5 global reagents IN gastric cancer diagnostics market, By product type, 2019-2028 (USD million)

TABLE 6 Global instruments in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 7 Global services in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 8 global gastric cancer diagnostics market, By diagnostic type, 2019-2028 (USD million)

TABLE 9 Global confirmatory test in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 10 Global confirmatory test in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 11 Global imaging tests in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 12 Global biomarker in Gastric cancer diagnostics Market, By diagnostic type, 2019-2028 (USD Million)

TABLE 13 Global gastric cancer screening tests/physical exam in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 14 global gastric cancer diagnostics market, By age group, 2019-2028 (USD million)

TABLE 15 Global geriatrics in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 16 Global adult in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 17 Global pediatric in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 18 global gastric cancer diagnostics market, By disease type, 2019-2028 (USD million)

TABLE 19 Global intestinal or diffuse ADENOCARCINOMA in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 20 Global carcinoid tumor in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global gastrointestinal stromal tumor in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 22 Global gastric lymphoma in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global others in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 24 global gastric cancer diagnostics market, By stage, 2019-2028 (USD million)

TABLE 25 Global stage i in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global stage i in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 27 Global stage iI in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global stage iI in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 29 Global stage iII in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global stage iIi in Gastric cancer diagnostics Market, By stage, 2019-2028 (USD Million)

TABLE 31 Global stage 0 in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 32 global gastric cancer diagnostics market, By gender, 2019-2028 (USD million)

TABLE 33 Global male in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 34 Global female in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 35 global gastric cancer diagnostics market, By sample type, 2019-2028 (USD million)

TABLE 36 Global stool in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 37 Global tissue in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 38 Global blood in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 39 Global urine in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 40 global gastric cancer diagnostics market, By end user, 2019-2028 (USD million)

TABLE 41 Global HOSPITALS in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 42 Global diagnostic laboratories in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 43 Global cancer research institutes in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 44 Global oncology specialty clinics in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global others in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 46 global gastric cancer diagnostics market, By distribution channel, 2019-2028 (USD million)

TABLE 47 Global direct tenders in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 48 Global Retail Sales in Gastric cancer diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 49 GLOBAL gastric cancer diagnostics market, By region, 2019-2028 (usd million)

TABLE 50 NORTH AMERICA Gastric Cancer Diagnostics Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 51 North America Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 52 North America Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 53 North America Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 54 North America Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 55 North America Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 56 North America Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 57 North America Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 58 North America Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 59 North America Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 60 North America Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 61 North America Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 62 North America Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 63 North America Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 64 North America Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 65 North America Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 66 North America Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 67 North America Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 68 North America Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 69 U.S. Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 70 U.S. Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 71 U.S. Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 72 U.S. Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 73 U.S. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 74 U.S. Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 75 U.S. Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 76 U.S. Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 77 U.S. Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 78 U.S. Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 79 U.S. Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 80 U.S. Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 81 U.S. Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 82 U.S. Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 83 U.S. Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 84 U.S. Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 85 U.S. Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 86 U.S. Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 87 Canada Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 88 Canada Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 89 Canada Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 90 Canada Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 91 Canada Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 92 Canada Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 93 Canada Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 94 Canada Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 95 Canada Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 96 Canada Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 97 Canada Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 98 Canada Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 99 Canada Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 100 Canada Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 101 Canada Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 102 Canada Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 103 Canada Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 104 Canada Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 105 Mexico Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 106 Mexico Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 107 Mexico Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 108 Mexico Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 109 Mexico Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 110 Mexico Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 111 Mexico Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 112 Mexico Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 113 Mexico Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 114 Mexico Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 115 Mexico Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 116 Mexico Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 117 Mexico Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 118 Mexico Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 119 Mexico Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 120 Mexico Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 121 Mexico Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 122 Mexico Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 123 EUROPE Gastric Cancer Diagnostics Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 124 Europe Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 125 Europe Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 126 Europe Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 127 Europe Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 128 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 129 Europe Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 130 Europe Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 131 Europe Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 132 Europe Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 133 Europe Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 134 Europe Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 135 Europe Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 136 Europe Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 137 Europe Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 138 Europe Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 139 Europe Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 140 Europe Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 141 Europe Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 142 Germany Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 143 Germany Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 144 Germany Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 145 Germany Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 146 Germany Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 147 Germany Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 148 Germany Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 149 Germany Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 150 Germany Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 151 Germany Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 152 Germany Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 153 Germany Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 154 Germany Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 155 Germany Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 156 Germany Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 157 Germany Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 158 Germany Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 159 Germany Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 160 France Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 161 France Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 162 France Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 163 France Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 164 France Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 165 France Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 166 France Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 167 France Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 168 France Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 169 France Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 170 France Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 171 France Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 172 France Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 173 France Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 174 France Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 175 France Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 176 France Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 177 France Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 178 U.K. Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 179 U.K. Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 180 U.K. Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 181 U.K. Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 182 U.K. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 183 U.K. Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 184 U.K. Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 185 U.K. Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 186 U.K. Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 187 U.K. Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 188 U.K. Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 189 U.K. Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 190 U.K. Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 191 U.K. Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 192 U.K. Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 193 U.K. Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 194 U.K. Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 195 U.K. Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 196 Russia Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 197 Russia Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 198 Russia Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 199 Russia Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 200 Russia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 201 Russia Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 202 Russia Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 203 Russia Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 204 Russia Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 205 Russia Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 206 Russia Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 207 Russia Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 208 Russia Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 209 Russia Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 210 Russia Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 211 Russia Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 212 Russia Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 213 Russia Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 214 Italy Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 215 Italy Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 216 Italy Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 217 Italy Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 218 Italy Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 219 Italy Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 220 Italy Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 221 Italy Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 222 Italy Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 223 Italy Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 224 Italy Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 225 Italy Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 226 Italy Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 227 Italy Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 228 Italy Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 229 Italy Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 230 Italy Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 231 Italy Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 232 Spain Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 233 Spain Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 234 Spain Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 235 Spain Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 236 Spain Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 237 Spain Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 238 Spain Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 239 Spain Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 240 Spain Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 241 Spain Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 242 Spain Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 243 Spain Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 244 Spain Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 245 Spain Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 246 Spain Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 247 Spain Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 248 Spain Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 249 Spain Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 250 Belgium Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 251 Belgium Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 252 Belgium Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 253 Belgium Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 254 Belgium Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 255 Belgium Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 256 Belgium Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 257 Belgium Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 258 Belgium Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 259 Belgium Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 260 Belgium Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 261 Belgium Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 262 Belgium Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 263 Belgium Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 264 Belgium Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 265 Belgium Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 266 Belgium Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 267 Belgium Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 268 Netherlands Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 269 Netherlands Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 270 Netherlands Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 271 Netherlands Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 272 Netherlands Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 273 Netherlands Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 274 Netherlands Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 275 Netherlands Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 276 Netherlands Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 277 Netherlands Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 278 Netherlands Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 279 Netherlands Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 280 Netherlands Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 281 Netherlands Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 282 Netherlands Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 283 Netherlands Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 284 Netherlands Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 285 Netherlands Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 286 Turkey Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 287 Turkey Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 288 Turkey Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 289 Turkey Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 290 Turkey Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 291 Turkey Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 292 Turkey Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 293 Turkey Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 294 Turkey Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 295 Turkey Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 296 Turkey Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 297 Turkey Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 298 Turkey Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 299 Turkey Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 300 Turkey Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 301 Turkey Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 302 Turkey Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 303 Turkey Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 304 Switzerland Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 305 Switzerland Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 306 Switzerland Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 307 Switzerland Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 308 Switzerland Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 309 Switzerland Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 310 Switzerland Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 311 Switzerland Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 312 Switzerland Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 313 Switzerland Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 314 Switzerland Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 315 Switzerland Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 316 Switzerland Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 317 Switzerland Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 318 Switzerland Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 319 Switzerland Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 320 Switzerland Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 321 Switzerland Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 322 Rest of Europe Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 323 ASIA-PACIFIC Gastric Cancer Diagnostics Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 324 Asia-Pacific Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 325 Asia-Pacific Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 326 Asia-Pacific Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 327 Asia-Pacific Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 328 Asia-Pacific Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 329 Asia-Pacific Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 330 Asia-Pacific Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 331 Asia-Pacific Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 332 Asia-Pacific Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 333 Asia-Pacific Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 334 Asia-Pacific Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 335 Asia-Pacific Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 336 Asia-Pacific Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 337 Asia-Pacific Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 338 Asia-Pacific Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 339 Asia-Pacific Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 340 Asia-Pacific Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 341 Asia-Pacific Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 342 SOUTH KOREA Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 343 SOUTH KOREA Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 344 SOUTH KOREA Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 345 SOUTH KOREA Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 346 SOUTH KOREA Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 347 SOUTH KOREA Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 348 SOUTH KOREA Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 349 SOUTH KOREA Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 350 SOUTH KOREA Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 351 SOUTH KOREA Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 352 SOUTH KOREA Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 353 SOUTH KOREA Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 354 SOUTH KOREA Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 355 SOUTH KOREA Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 356 SOUTH KOREA Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 357 SOUTH KOREA Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 358 SOUTH KOREA Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 359 SOUTH KOREA Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 360 JAPAN Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 361 JAPAN Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 362 JAPAN Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 363 JAPAN Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 364 JAPAN Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 365 JAPAN Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 366 JAPAN Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 367 JAPAN Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 368 JAPAN Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 369 JAPAN Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 370 JAPAN Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 371 JAPAN Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 372 JAPAN Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 373 JAPAN Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 374 JAPAN Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 375 JAPAN Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 376 JAPAN Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 377 JAPAN Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 378 CHINA Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 379 CHINA Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 380 CHINA Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 381 CHINA Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 382 CHINA Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 383 CHINA Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 384 CHINA Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 385 CHINA Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 386 CHINA Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 387 CHINA Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 388 CHINA Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 389 CHINA Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 390 CHINA Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 391 CHINA Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 392 CHINA Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 393 CHINA Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 394 CHINA Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 395 CHINA Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 396 Australia Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 397 Australia Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 398 Australia Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 399 Australia Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 400 Australia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 401 Australia Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 402 Australia Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 403 Australia Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 404 Australia Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 405 Australia Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 406 Australia Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 407 Australia Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 408 Australia Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 409 Australia Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 410 Australia Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 411 Australia Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 412 Australia Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 413 Australia Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 414 Singapore Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 415 Singapore Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 416 Singapore Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 417 Singapore Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 418 Singapore Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 419 Singapore Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 420 Singapore Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 421 Singapore Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 422 Singapore Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 423 Singapore Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 424 Singapore Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 425 Singapore Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 426 Singapore Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 427 Singapore Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 428 Singapore Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 429 Singapore Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 430 Singapore Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 431 Singapore Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 432 india Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 433 India Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 434 India Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 435 India Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 436 India Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 437 India Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 438 India Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 439 India Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 440 India Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 441 India Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 442 India Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 443 India Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 444 India Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 445 India Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 446 India Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 447 India Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 448 India Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 449 India Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 450 THAILAND Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 451 THAILAND Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 452 THAILAND Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 453 THAILAND Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 454 THAILAND Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 455 THAILAND Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 456 THAILAND Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 457 THAILAND Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 458 THAILAND Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 459 THAILAND Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 460 THAILAND Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 461 THAILAND Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 462 THAILAND Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 463 THAILAND Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 464 THAILAND Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 465 THAILAND Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 466 THAILAND Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 467 THAILAND Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 468 Malaysia Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 469 Malaysia Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 470 Malaysia Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 471 Malaysia Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 472 Malaysia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 473 Malaysia Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 474 Malaysia Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 475 Malaysia Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 476 Malaysia Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 477 Malaysia Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 478 Malaysia Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 479 Malaysia Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 480 Malaysia Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 481 Malaysia Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 482 Malaysia Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 483 Malaysia Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 484 Malaysia Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 485 Malaysia Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 486 INDONESIA Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 487 INDONESIA Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 488 INDONESIA Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 489 INDONESIA Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 490 INDONESIA Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 491 INDONESIA Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 492 INDONESIA Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 493 INDONESIA Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 494 INDONESIA Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 495 INDONESIA Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 496 INDONESIA Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 497 INDONESIA Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 498 INDONESIA Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 499 INDONESIA Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 500 INDONESIA Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 501 INDONESIA Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 502 INDONESIA Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 503 INDONESIA Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 504 PHILIPPINES Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 505 PHILIPPINES Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 506 PHILIPPINES Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 507 PHILIPPINES Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 508 PHILIPPINES Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 509 PHILIPPINES Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 510 PHILIPPINES Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 511 PHILIPPINES Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 512 PHILIPPINES Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 513 PHILIPPINES Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 514 PHILIPPINES Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 515 PHILIPPINES Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 516 PHILIPPINES Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 517 PHILIPPINES Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 518 PHILIPPINES Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 519 PHILIPPINES Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 520 PHILIPPINES Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 521 PHILIPPINES Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 522 Rest of ASIA-PACIFIC Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 523 SOUTH AMERICA Gastric Cancer Diagnostics Market, By COUNTRY 2019-2028 (USD Million)

TABLE 524 South America Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 525 South America Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 526 South America Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 527 South America Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 528 South America Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 529 South America Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 530 South America Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 531 South America Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 532 South America Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 533 South America Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 534 South America Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 535 South America Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 536 South America Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 537 South America Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 538 South America Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 539 South America Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 540 South America Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 541 South America Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 542 Brazil Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 543 Brazil Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 544 Brazil Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 545 Brazil Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 546 Brazil Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 547 Brazil Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 548 Brazil Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 549 Brazil Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 550 Brazil Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 551 Brazil Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 552 Brazil Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 553 Brazil Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 554 Brazil Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 555 Brazil Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 556 Brazil Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 557 Brazil Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 558 Brazil Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 559 Brazil Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 560 Argentina Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 561 Argentina Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 562 Argentina Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 563 Argentina Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 564 Argentina Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 565 Argentina Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 566 Argentina Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 567 Argentina Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 568 Argentina Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 569 Argentina Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 570 Argentina Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 571 Argentina Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 572 Argentina Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 573 Argentina Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 574 Argentina Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 575 Argentina Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 576 Argentina Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 577 Argentina Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 578 Rest of South America Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 579 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 580 Middle East and Africa Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 581 Middle East and Africa Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 582 Middle East and Africa Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 583 Middle East and Africa Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 584 Middle East and Africa Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 585 Middle East and Africa Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 586 Middle East and Africa Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 587 Middle East and Africa Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 588 Middle East and Africa Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 589 Middle East and Africa Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 590 Middle East and Africa Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 591 Middle East and Africa Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 592 Middle East and Africa Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 593 Middle East and Africa Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 594 Middle East and Africa Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 595 Middle East and Africa Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 596 Middle East and Africa Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 597 Middle East and Africa Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 598 South Africa Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 599 South Africa Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 600 South Africa Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 601 South Africa Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 602 South Africa Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 603 South Africa Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 604 South Africa Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 605 South Africa Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 606 South Africa Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 607 South Africa Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 608 South Africa Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 609 South Africa Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 610 South Africa Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 611 South Africa Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 612 South Africa Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 613 South Africa Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 614 South Africa Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 615 South Africa Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 616 Saudi Arabia Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 617 Saudi Arabia Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 618 Saudi Arabia Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 619 Saudi Arabia Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 620 Saudi Arabia Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 621 Saudi Arabia Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 622 Saudi Arabia Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 623 Saudi Arabia Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 624 Saudi Arabia Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 625 Saudi Arabia Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 626 Saudi Arabia Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 627 Saudi Arabia Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 628 Saudi Arabia Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 629 Saudi Arabia Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 630 Saudi Arabia Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 631 Saudi Arabia Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 632 Saudi Arabia Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 633 Saudi Arabia Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 634 U.A.E. Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 635 U.A.E. Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 636 U.A.E. Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 637 U.A.E. Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 638 U.A.E. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 639 U.A.E. Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 640 U.A.E. Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 641 U.A.E. Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 642 U.A.E. Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 643 U.A.E. Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 644 U.A.E. Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 645 U.A.E. Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 646 U.A.E. Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 647 U.A.E. Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 648 U.A.E. Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 649 U.A.E. Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 650 U.A.E. Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 651 U.A.E. Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 652 Egypt Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 653 Egypt Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 654 Egypt Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 655 Egypt Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 656 Egypt Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 657 Egypt Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 658 Egypt Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 659 Egypt Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 660 Egypt Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 661 Egypt Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 662 Egypt Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 663 Egypt Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 664 Egypt Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 665 Egypt Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 666 Egypt Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 667 Egypt Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 668 Egypt Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 669 Egypt Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 670 Israel Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 671 Israel Reagents & Consumables in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 672 Israel Kits in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 673 Israel Reagents in Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 674 Israel Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 675 Israel Confirmatory tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 676 Israel Imaging Tests in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 677 Israel Biomarker in Gastric Cancer Diagnostics Market, By Diagnostic Type, 2019-2028 (USD Million)

TABLE 678 Israel Gastric Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 679 Israel Gastric Cancer Diagnostics Market, By Disease Type, 2019-2028 (USD Million)

TABLE 680 Israel Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 681 Israel Stage I in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 682 Israel Stage II in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 683 Israel Stage III in Gastric Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 684 Israel Gastric Cancer Diagnostics Market, By Gender, 2019-2028 (USD Million)

TABLE 685 Israel Gastric Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 686 Israel Gastric Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 687 Israel Gastric Cancer Diagnostics Market, By Distribution CHannel, 2019-2028 (USD Million)

TABLE 688 Rest of Middle East & Africa Gastric Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Global GASTRIC CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 global Gastric cancer diagnostics market: DROC ANALYSIS

FIGURE 4 Global Gastric cancer diagnostics market: Global VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Global Gastric cancer diagnostics market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Gastric cancer diagnostics market: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Gastric cancer diagnostics market: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL GASTRIC CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL gastric cancer diagnostics market: MARKET END USER COVERAGE GRID

FIGURE 11 Global Gastric cancer diagnostics market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Gastric cancer diagnostics market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 Increase in incidence of gastrointestinal tumors, lymphoma, and adenocarcinoma is expected to DRIVe THE global Gastric cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 reagents and consumables SEGMENT is expected to account for the largest share of the global GASTRIC CANCER DIAGNOSTICS MARKET in 2021 & 2028

FIGURE 15 ASIA-PACIFIC is the fastest growing market FOR the Gastric cancer diagnostics MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF global Gastric cancer diagnostics Market

FIGURE 17 global gastric cancer diagnostics market: By product type, 2020

FIGURE 18 global gastric cancer diagnostics market: By product type, 2021-2028 (USD Million)

FIGURE 19 global gastric cancer diagnostics market: By product type, CAGR (2021-2028)

FIGURE 20 global gastric cancer diagnostics market: By product type, LIFELINE CURVE

FIGURE 21 global gastric cancer diagnostics market: By diagnostic type, 2020

FIGURE 22 global gastric cancer diagnostics market: By diagnostic type, 2021-2028 (USD Million)

FIGURE 23 global gastric cancer diagnostics market: By diagnostic type, CAGR (2021-2028)

FIGURE 24 global gastric cancer diagnostics market: By diagnostic type, LIFELINE CURVE

FIGURE 25 global gastric cancer diagnostics market: By age group, 2020

FIGURE 26 global gastric cancer diagnostics market: By age group, 2021-2028 (USD Million)

FIGURE 27 global gastric cancer diagnostics market: By age group, CAGR (2021-2028)

FIGURE 28 global gastric cancer diagnostics market: By age group, LIFELINE CURVE

FIGURE 29 global gastric cancer diagnostics market: By disease type, 2020

FIGURE 30 global gastric cancer diagnostics market: By disease type, 2021-2028 (USD Million)

FIGURE 31 global gastric cancer diagnostics market: By disease type, CAGR (2021-2028)

FIGURE 32 global gastric cancer diagnostics market: By disease type, LIFELINE CURVE

FIGURE 33 global gastric cancer diagnostics market: By stage, 2020

FIGURE 34 global gastric cancer diagnostics market: By stage, 2021-2028 (USD Million)

FIGURE 35 global gastric cancer diagnostics market: By stage, CAGR (2021-2028)

FIGURE 36 global gastric cancer diagnostics market: By stage, LIFELINE CURVE

FIGURE 37 global gastric cancer diagnostics market: By gender, 2020

FIGURE 38 global gastric cancer diagnostics market: By gender, 2021-2028 (USD Million)

FIGURE 39 global gastric cancer diagnostics market: By gender, CAGR (2021-2028)

FIGURE 40 global gastric cancer diagnostics market: By gender, LIFELINE CURVE

FIGURE 41 global gastric cancer diagnostics market: By sample type, 2020

FIGURE 42 global gastric cancer diagnostics market: By sample type, 2021-2028 (USD Million)

FIGURE 43 global gastric cancer diagnostics market: By sample type, CAGR (2021-2028)

FIGURE 44 global gastric cancer diagnostics market: By sample type, LIFELINE CURVE

FIGURE 45 global gastric cancer diagnostics market: By end user, 2020

FIGURE 46 global gastric cancer diagnostics market: By end user, 2021-2028 (USD Million)

FIGURE 47 global gastric cancer diagnostics market: By end user, CAGR (2021-2028)

FIGURE 48 global gastric cancer diagnostics market: By end user, LIFELINE CURVE

FIGURE 49 global gastric cancer diagnostics market: By distribution channel, 2020

FIGURE 50 global gastric cancer diagnostics market: By distribution channel, 2021-2028 (USD Million)

FIGURE 51 global gastric cancer diagnostics market: By distribution channel, CAGR (2021-2028)

FIGURE 52 global gastric cancer diagnostics market: By distribution channel, LIFELINE CURVE

FIGURE 53 GLOBAL gastric cancer diagnostics market: SNAPSHOT (2020)

FIGURE 54 GLOBAL gastric cancer diagnostics market: by region (2020)

FIGURE 55 GLOBAL gastric cancer diagnostics market: by region (2021 & 2028)

FIGURE 56 GLOBAL gastric cancer diagnostics market: by region (2020 & 2028)

FIGURE 57 GLOBAL gastric cancer diagnostics market: by product TYPE (2021-2028)

FIGURE 58 NORTH AMERICA Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 59 NORTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 60 NORTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 61 NORTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 62 NORTH AMERICA Gastric Cancer Diagnostics MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 63 EUROPE Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 64 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 65 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 66 EUROPE Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 67 EUROPE Gastric Cancer Diagnostics MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 68 ASIA-PACIFIC Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 69 ASIA-PACIFIC Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 70 ASIA-PACIFIC Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 71 ASIA-PACIFIC Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 72 ASIA-PACIFIC Gastric Cancer Diagnostics MARKET: BY product TYPE (2021-2028)

FIGURE 73 SOUTH AMERICA Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 74 SOUTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 75 SOUTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 76 SOUTH AMERICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 77 SOUTH AMERICA Gastric Cancer Diagnostics MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 78 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics MARKET: SNAPSHOT (2020)

FIGURE 79 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020)

FIGURE 80 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2021 & 2028)

FIGURE 81 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics MARKET: BY COUNTRY (2020 & 2028)

FIGURE 82 MIDDLE EAST AND AFRICA Gastric Cancer Diagnostics MARKET: BY product TYPE (2021-2028)

FIGURE 83 Global Gastric Cancer diagnostics Market: company share 2020 (%)

FIGURE 84 North America Gastric Cancer diagnostics Market: company share 2020 (%)

FIGURE 85 EUROPE Gastric Cancer diagnostics Market: company share 2020 (%)

FIGURE 86 ASIA-PACIFIC Gastric Cancer diagnostics Market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The gastric cancer diagnostics market size will be worth USD 1,950.82 million by 2030.
The growth rate of the gastric cancer diagnostics market is 8.% by 2030.
Increase in incidence of gastrointestinal tumors, lymphoma, adenocarcinoma, rise in alcohol consumption & surge in smoking drives the gastric cancer diagnostics market.
Product type, diagnostic type, age group, disease type, stage, gender, sample, end user, and distribution channel are the factors on which the gastric cancer diagnostics market research is based.
Major companies in the gastric cancer diagnostics market are Myriad Genetics, Inc., ACON Laboratories, Inc., Teco Diagnostics., Vela Diagnostics, Abbott, AdvaCare Pharma, Fujirebio ( An H.U. Group company), Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, General Electric, Agilent Technologies, Inc., Endofotonics Pte Ltd, Biohit Oyj, BIOCEPT, INC., FOUNDATION MEDICINE, INC., DiaSorin S.p.A, Paragon Genomics, Inc., BIOMÉRIEUX, and QIAGEN among others.